Related Experiment Video
Updated: Jun 6, 2026
06:59
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Preoperative embolization in mediastinal Castleman's disease
B Aydemir1, T Okay, O Imamoglu
1Department of Thoracic Surgery, Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey. aydemirb@hotmail.com
The Thoracic and Cardiovascular Surgeon
|November 27, 2010
Summary
Castleman's disease, a rare lymphoproliferative disorder, can be surgically treated. Preoperative embolization effectively managed bleeding risks in a mediastinal case due to hypervascularity.
Area of Science:
- Oncology
- Vascular Surgery
- Radiology
Background:
- Castleman's disease is a rare lymphoproliferative disorder with unknown etiology.
- It can manifest at any lymph tissue site, with complete resection being the definitive treatment.
- High vascularization presents a significant surgical challenge due to potential bleeding.
Observation:
- This study details the surgical management of a mediastinal Castleman's disease case.
- Hypervascularization was identified via thoracic CT, necessitating preoperative intervention.
- Embolization was employed as a preoperative strategy to mitigate bleeding risks.
Findings:
- Preoperative embolization successfully addressed the hypervascular nature of the mediastinal mass.
- This approach facilitated safer surgical resection by reducing intraoperative bleeding.
- The case highlights the utility of embolization in managing complex Castleman's disease presentations.
Implications:
- Preoperative embolization is a viable strategy for hypervascular mediastinal Castleman's disease.
- This technique can improve surgical outcomes and patient safety.
- Further research into multimodal treatment approaches for Castleman's disease is warranted.
